1
Clinical Trials associated with BCG(Anhui Zhifei Longcom Biologic Pharmacy)Phase I Clinical Trial to Evaluate the Safety and Tolerability of BCG for Therapeutic Use in Preventing Postoperative Recurrence of Non-muscular Invasive Bladder Cancer in People Aged 18 and Over
This clinical study adopted a single-arm, open, single-centertrial design. The purpose of this study was to evaluate the safety and tolerability, PK characteristics, shedding and immune response characteristics of BCG for therapeutic use developed by Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. in patients aged 18 and over after transethral resection of non-muscular invasive bladder cancer.
100 Clinical Results associated with BCG(Anhui Zhifei Longcom Biologic Pharmacy)
100 Translational Medicine associated with BCG(Anhui Zhifei Longcom Biologic Pharmacy)
100 Patents (Medical) associated with BCG(Anhui Zhifei Longcom Biologic Pharmacy)
100 Deals associated with BCG(Anhui Zhifei Longcom Biologic Pharmacy)